Bank of Hawaii’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-8,789
Closed -$726K 253
2022
Q3
$726K Buy
8,789
+113
+1% +$10.9K 0.05% 138
2022
Q2
$825K Buy
+8,676
New +$898K 0.05% 138
2020
Q3
Sell
-8,325
Closed -$575K 267
2020
Q2
$575K Sell
8,325
-3,750
-31% -$266K 0.04% 177
2020
Q1
$759K Buy
12,075
+3,990
+49% +$288K 0.07% 154
2019
Q4
$629K Hold
8,085
0.04% 216
2019
Q3
$593K Buy
+8,085
New +$568K 0.04% 210
2016
Q4
Sell
-8,715
Closed -$350K 305
2016
Q3
$350K Buy
8,715
+60
+0.7% +$2.26K 0.03% 257
2016
Q2
$288K Sell
8,655
-30
-0.3% -$1.03K 0.03% 264
2016
Q1
$256K Sell
8,685
-35,235
-80% -$972K 0.03% 278
2015
Q4
$1.16M Sell
43,920
-120
-0.3% -$3.12K 0.13% 142
2015
Q3
$1.04M Sell
44,040
-34,650
-44% -$836K 0.12% 155
2015
Q2
$1.87M Buy
78,690
+1,290
+2% +$29.1K 0.19% 107
2015
Q1
$1.84M Sell
77,400
-3,150
-4% -$70.7K 0.18% 119
2014
Q4
$1.71M Buy
+80,550
New +$1.62M 0.16% 130

Other funds holding EW

Bank of Hawaii's EW Position: Q4 2022 in Review

Bank of Hawaii sold out of Edwards Lifesciences (EW) in Q4 2022, closing a stake of 8,789 shares — an estimated $726K sold.

Bank of Hawaii first reported a position in EW in Q4 2014 and held it in 14 quarters. The position peaked at $1.87M in Q2 2015. 1,229 funds tracked by Wall St. Rank hold EW as of Q4 2022.

  • Bank of Hawaii reported no remaining Edwards Lifesciences position as of Q4 2022 after selling out during the quarter.
  • Bank of Hawaii sold 8,789 Edwards Lifesciences shares in Q4 2022, an estimated $726K.
  • Bank of Hawaii first reported a position in Edwards Lifesciences in Q4 2014 and held it in 14 quarters.
  • Bank of Hawaii's Edwards Lifesciences position peaked at $1.87M in Q2 2015.
  • 1,229 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2022.

Based on Bank of Hawaii's 13F filing for Q4 2022, filed 30 Jan 2023.